Carton-label-20mg (Mitomycin Spl Carton Label 20mg)
Mitomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-484
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mitomycin (NDC 68083-484). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Carton-label-5mg (Mitomycin Spl Carton Label 5mg)
Container-label-20mg (Mitomycin Spl Container Label 20mg)
This appears to be a description of a medication called Mitomycin, used for injection. It warns that it should be stored in a container in a carton at a temperature between 27 and 50 degrees, and that it should be administered intravenously to avoid tissue damage. It also states that it is a cytotoxic agent and should be refrigerated between 2 and 8 degrees Celsius, and discarded after 14 days if unvengerated. If vials are single-dose, they should be discarded after 7 days.*
Container-label-20mg (Mitomycin Spl Container Label 5mg)
This is a vial containing 5 mg of mitomycin and 10 mg of mannitol manufactured by LeRReoe and Prams Limited. The product is for injection and is immediately required to be diluted before use. The usual dosage is 5 mg per vial, and it should only be administered intravenously while avoiding tissue damage. This is a cytotoxic agent that should be refrigerated at 2-8°C and discarded after 14 days. The vial comes in a single-dose and should be used within 7 days of opening.*
Mitomycin-spl-structure (Mitomycin Spl Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
